- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00400868
Effectiveness of Occupational Therapy in Patients With Rheumatoid Arthritis(RCT)
A Randomized Controlled Study to Evaluate the Short- and Long-term Effectiveness of an Individualized Resource Oriented Occupational Therapy for Patients With Rheumatoid Arthritis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Joint Protection (JP)is an important intervention in the management of people with arthritis. Altering working methods (e.g. use of proximal joints, dynamic activities), energy conservation (balance between activity and rest) and using assistive devices should place less strain on joint structures weakened by the disease process. These strategies ought to decrease pain and stress on joints, improve function, and facilitate maintaining social roles.
The effectiveness of JP has been evaluated in a number of studies, all in a group setting. JP has beneficial short-term effects on pain and function in patients with established RA and moderate functional problems. Using assistive devices reduces pain during task performance in comparison to normal methods and altering working methods significantly reduces difficulties in activities of daily living (ADL). However this generally does not result in significant behavioral changes and a long-term impact on reducing pain and maintaining function may only be reached if JP is taught using behavioral education methods. Additionally, adherence of RA patients to different interventions is generally modest, which may well determine the effectiveness of any given intervention, especially in the long-term.
All previous studies were carried out in group settings, however, in Switzerland, standard JP education is provided on a one-to-one basis and an individualized education is assumed to be a promising approach.
This clinical trial aims to test the hypothesis that an individualized, resource-oriented JP education in RA patients leads to a better therapy success in the short and long-term, compared to problem-oriented standard JP education in terms of joint protection behavior. Secondary outcome parameters are self-perception, general and specific self-efficacy and general and health-related quality of life.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, 3010
- University Hospital
-
Valens, Switzerland, 7317
- Rehabilitation Clinic
-
Zurich, Switzerland, 8008
- Schulthess Klinik
-
Zurich, Switzerland, 8091
- University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of RA according to ACR Guidelines (1988)
- Actual hand pain on activity or history of wrist and/or metacarpophalangeal(MCP) joint pain and inflammation
- Referred to OT for a Joint Protection intervention program
- Willingness to comply with the randomly assigned treatment and informed consent
- Functional Class: 2 to 4
- German speaking/understanding/reading
- Sufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation
Exclusion Criteria:
- Functional class 1 (anticipated self-exclusion, as patients in class 1 will not be referred to JP).
- Severe finger, hand, elbow or shoulder deformities
- Insufficient ability to understand, speak and read the German language
- Insufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: standard joint protection education
psycho-educational joint protection vs. usual care (standard joint protection education)
|
individualized psycho-educational joint protection education, 4-times over 3 weeks; one additional booster session 2 months later
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
joint protection behavior
Time Frame: before/after intervention, 3,6,12 months follow up
|
before/after intervention, 3,6,12 months follow up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
General quality of life
Time Frame: before intervention, 3,6,12 months follow up
|
before intervention, 3,6,12 months follow up
|
Health related quality of life / physical functional ability
Time Frame: before intervention, 6,12 months follow up
|
before intervention, 6,12 months follow up
|
Self-Illness Separation SIS, derived from the PRISM (intervention group)
Time Frame: before/during/after intervention, 3,6,12 months follow up
|
before/during/after intervention, 3,6,12 months follow up
|
Goals achievement (intervention group)
Time Frame: during/after intervention, 3,6,12 months follow up
|
during/after intervention, 3,6,12 months follow up
|
Hand impairment status, including pain
Time Frame: before/during/after intervention, 3,6,12 months follow up
|
before/during/after intervention, 3,6,12 months follow up
|
Arthritis self-efficacy and JP-specific self-efficacy
Time Frame: before/after intervention, 3,6,12 months follow up
|
before/after intervention, 3,6,12 months follow up
|
Self-perceived disease activity
Time Frame: before intervention, 12 months follow up
|
before intervention, 12 months follow up
|
Clinical data
Time Frame: before intervention, 3, 12 months follow up
|
before intervention, 3, 12 months follow up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Robert de Bie, Prof, PhD, University of Maastricht NL
- Principal Investigator: Karin Niedermann, MPH, University Hospital of Zurich, CH
- Study Director: Stefan Buchi, MD, University Hospital of Zurich, CH
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- niedk_EK444_
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
National Institute of Arthritis and Musculoskeletal...Children's Hospital Medical Center, CincinnatiCompleted
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedRheumatoid Arthritis | Juvenile Rheumatoid ArthritisUnited States
-
University of Missouri-ColumbiaCompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Universidad Autonoma de Nuevo LeonCompletedRheumatoId ArthritisMexico
-
Hamad Medical CorporationUnknownRHEUMATOID ARTHRITISQatar
Clinical Trials on psycho-educational Joint protection education
-
Medical University of ViennaCompletedCovid19 | Psychological Stress | Pediatric Psychiatric DisorderAustria
-
Hacettepe UniversityCompleted
-
University Hospital Inselspital, BerneTerminatedHeart Patients After ICD ImplantationSwitzerland
-
Peking UniversityRecruitingDepression | Stroke | Rehabilitation | InterventionChina
-
Ersta Sköndal University CollegeKarolinska Institutet; Lund University; Linnaeus UniversityUnknown
-
Massachusetts General HospitalAmerican Lung AssociationRecruiting
-
University of the Basque Country (UPV/EHU)Universidad Pública de Navarra; Ministerio de Economía y Competitividad, SpainCompletedOverweight Children With Type 2 Diabetes RiskSpain
-
Gannon UniversityUniversity of MalagaUnknownPain | OsteoarthritisUnited States
-
University Hospital, GhentCompleted
-
Consorci Hospitalari de VicGovernment of CataloniaNot yet recruiting